Musk’s Neuralink got the green light. Brain implants will arrive in no less than 10 years

20230525_182110
Neuralink is another of Elon Musk's highly ambitious projects, the CEO of Tesla, a brilliant visionary and an enthusiast for space exploration. The concept of a brain implant that can deliver mRNA to cells represents a significant breakthrough, not only in the field of healthcare.

Neuralink defines the future

Conditions such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, cancer, and other chronic illnesses may soon become a thing of the past. Imagine being able to control your phone with just your thoughts. Could we really be on the brink of living in a world reminiscent of movies like “Johnny Mnemonic” or “Total Recall” in the coming years?

However, not everyone shares Musk’s enthusiasm. Some skeptics point out the potential risks associated with such implants, such as the misuse of personal data or, in the worst-case scenario, the loss of individual identity.

origin

Photo by Greek City Times 

Brain implants within 10 years

That scenario seems rather far-fetched, but it’s an idea that naturally comes to mind. Just think about artificial intelligence. Despite its undeniable benefits, there are voices advocating for caution and restraint.

But let’s return to Musk. Kip Ludwig, former program director of neural engineering at the NIH, has stated that Neuralink will require at least another ten years of development before it can be fully deployed for commercial use as a Brain-Machine Interface (BMI). This is despite the fact that they received approval from the U.S. Food and Drug Administration at the end of May.

He emphasized that human experiments of this nature are highly delicate matters that require extreme caution and meticulous selection of test subjects. On the other hand, he acknowledged that this technology could be absolutely invaluable in practical applications.

xc40-bev-og.jpg

The End of Diesel: Volvo Sets a Date!

Leave a Reply

Your email address will not be published. Required fields are marked *

Newsletter

Translate »